{"disease":{"id":"stage-iiia-b-nsclc-inoperable-lung-cancer","name":"stage iiia b nsclc inoperable lung cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01757288","title":"Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}